Day 1 - Saturday, 20 May 2017
CST: UTC + 08:00
Topics
Meeting category
Date(s)
20 May 2017 - 21 May 2017
Location
Shenzhen,
China
Organizer
Titanium Level Support
Sponsor logos
Asian Conference on Hepatitis and AIDS (ACHA) 2017
Related Enduring Materials
Enduring Materials
Program
Session 1: Co-infections -
HIV-HCV Coinfection
Clinical epidemiology and real-world anti-HCV efficacy for HIV-HCV coinfected patients in China
Fu-Sheng Wang, PhD
Beijing 302 Hospital, China
Advances in HIV and HBV co-infection research
The Efficacy of antiviral therapy on the regression of liver fibrosis in CHB
Session 2: Clinical case presentation and discussion on liver diseases -
A case report of liver injury associated with pregnancy
Session 3: HBV -
Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)
HBV Lifecycle and Intrahepatic Spread: New Targets for Curing HBV
Victorian Infectious Diseases Reference Laboratory
Clinical Trial Designs for Chronic Hepatitis B: Guiding Treatments towards Cures
Mother to child transmission of hepatitis B infection: Characteristics and prevention strategy
Yingxia Liu, MD, PhD
The Third People's Hospital of Shenzhen, China
Session 4: HCV -
WHO: Progress towards elimination of HCV as a public health threat -updates
Update on treatment for HCV disease in China
HCV infection and liver steatosis
Strategies for TCM treatment of Hepatitis C
Day 2 - Sunday, 21 May 2017
Session 5: HIV -
Eradication strategies
Implementing PrEP for HIV prevention
One PrEP Online survey in China
Session 6: Clinical case presentation and discussion on HIV -
A case of fever with multiple osseous lesions with unexpected diagnosis
Wei Lv, MD, PhD
Peking Union Medical College Hospital, China
A case of acute liver failure in HIV/HBV coinfection patient
Session 7: HIV -
PI based mono and dual-therapy
The clinical significance of low level viremia during treatment with cART
ARV toxicities and management
Adolescents and HIV: Guiding and Protecting the Vulnerable Population
Dushyantha Jayaweera, MD
Xinhua Hospital Affiliated to Shanghai Jiaotong University, Chin
General
Welcome
The Organizing Committee would like to thank all invited speakers and participants for their contribution to this workshop!
We would like to thank our supporters ViiV Healthcare, Gilead Science and Mylan for making this event possible.
General Information
Unique Features
- A program with a special focus on the needs in China and Asia
- A true scientific platform for local and regional clinicians and clinical researchers to present their data
- A unique opportunity for regional clinicians, researchers, and pharmaceutical companies to meet and collaborate
- A true scientific platform for local and regional clinicians and clinical researchers to present their data
- A unique opportunity for regional clinicians, researchers, and pharmaceutical companies to meet and collaborate
Meeting Objectives
This meeting aims to:
- Provide education on the latest treatment options for HBV, HCV, HIV and associated co-infections
- Present the latest research data, especially in the Asian context and translate knowledge into clinical practice
- Provide a platform for interaction and dialogue among different disciplines and facilitate collaborations among local, national and regional communities
- Provide education on the latest treatment options for HBV, HCV, HIV and associated co-infections
- Present the latest research data, especially in the Asian context and translate knowledge into clinical practice
- Provide a platform for interaction and dialogue among different disciplines and facilitate collaborations among local, national and regional communities
Learning Objectives
After participating in this activity, participants will be able to:
- Summarize the most recent results in drug development (including most recent clinical trial results) for HBV, HCV, and HIV
- Integrate the latest scientific results into daily clinical care to improve the treatment quality for HBV, HCV and HIV-positive individuals
- Summarize the most recent results in drug development (including most recent clinical trial results) for HBV, HCV, and HIV
- Integrate the latest scientific results into daily clinical care to improve the treatment quality for HBV, HCV and HIV-positive individuals
Practical Information
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this conference, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this conference. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Support
Platinum Level
Support
Endorsers
Language
Related Programs
